Title of article
Risk of adverse events with fibrates
Author/Authors
Alsheikh-Ali، نويسنده , , Alawi A. and Kuvin، نويسنده , , Jeffrey T. and Karas، نويسنده , , Richard H.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
4
From page
935
To page
938
Abstract
An increased risk for adverse events was observed with gemfibrozil relative to fenofibrate, predominantly driven by an increased rate of rhabdomyolysis. This difference was especially noticeable in patients taking the combination of gemfibrozil and a statin, particularly cerivastatin.
Journal title
American Journal of Cardiology
Serial Year
2004
Journal title
American Journal of Cardiology
Record number
1898184
Link To Document